In summary, our study demonstrates that the up-regulation of METTL1/WDR4 in AML patients increases the abundance of tRNA m7G modification, which promotes the leukaemogenesis of AML cells by facilitating the overall cellular translation efficiency. The gene discussed is METTL1; the disease is acute myeloid leukemia.